MTAC
NASDAQ:MTACU
MedTech Acquisition Corporation
- Stock
Last Close
9.56
10/08 20:00
Market Cap
83.86M
Beta: −0.03
Volume Today
176.27K
Avg: 58
PE Ratio
−2.71
PFCF: −8.68
Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|
average inventory | 2.01M - | ||||
average payables | 721.47K - | 4.17M 477.85% | |||
average receivables | 2.56M - | ||||
book value per share | 0.28 - | ||||
capex per share | |||||
capex to depreciation | -1.60 - | ||||
capex to operating cash flow | 0.02 - | ||||
capex to revenue | -0.06 - | ||||
cash per share | 0.86 - | ||||
days of inventory on hand | 356.59 - | ||||
days payables outstanding | 475.13 - | ||||
days sales outstanding | 70.08 - | ||||
debt to assets | 0.00 - | 0.12 5,311.65% | 0.06 47.24% | ||
debt to equity | 0.00 - | 0.36 15,470.18% | -0.06 116.94% | ||
dividend yield | |||||
earnings yield | 3.16 - | ||||
enterprise value | -1.33M - | 343.12K 125.70% | 3.97M 1,057.19% | -10.18M 356.44% | |
enterprise value over ebitda | 12.69 - | -0.03 100.25% | -0.46 1,353.96% | 0.19 141.22% | |
ev to operating cash flow | -0.20 - | -1.45 634.87% | 0.20 114.02% | ||
ev to sales | -0.55 - | ||||
free cash flow per share | -0.12 - | ||||
free cash flow yield | -1.56 - | ||||
graham net net | 0.27 - | ||||
graham number | 1.22 - | ||||
income quality | -0.36 - | -0.49 35.53% | 0.85 271.55% | ||
intangibles to total assets | 0 - | 0 | 0 | 0.04 Infinity% | |
interest coverage | 0.31 - | -3.38K 1,091,536.89% | |||
interest debt per share | -0.28 - | ||||
inventory turnover | 1.02 - | ||||
invested capital | 0.00 - | 0.36 15,470.18% | -0.06 116.94% | ||
market cap | 1.75M - | ||||
net current asset value | -6.85M - | -16.72M 144.33% | -13.29M 20.51% | -30.80M 131.68% | |
net debt to ebitda | 12.69 - | -0.03 100.25% | -0.26 712.44% | 0.19 173.77% | |
net income per share | 0.24 - | ||||
operating cash flow per share | -0.12 - | ||||
payables turnover | 0.77 - | ||||
receivables turnover | 5.21 - | ||||
research and ddevelopement to revenue | 1.59 - | ||||
return on tangible assets | -0.00 - | 0.02 4,658.59% | 0.27 1,341.93% | -2.40 974.75% | |
revenue per share | |||||
roe | -0.00 - | 0.02 4,823.70% | 0.85 4,048.66% | 2.28 168.47% | |
roic | -0.00 - | -0.01 2,946.26% | -0.28 2,021.21% | 2.22 895.86% | |
sales general and administrative to revenue | 1.27 - | ||||
shareholders equity per share | 0.28 - | ||||
stock based compensation to revenue | 0.08 - | ||||
tangible asset value | 243.16M - | 233.28M 4.06% | 6.53M 97.20% | -27.07M 514.25% | |
tangible book value per share | 0.28 - | ||||
working capital | 1.90M - | -531.73K 127.91% | -2.14M 302.85% | 6.17M 388.27% |
All numbers in USD (except ratios and percentages)